A Randomized Trial Assessing the Role of Arsenic Trioxide and/or ATRA During Consolidation Course in Newly Diagnosed Acute Promyelocytic Leukemia (APL).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Anthracyclines; Arsenic trioxide; Cytarabine; Tretinoin
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- 16 Apr 2014 Biomarkers information updated
- 03 May 2011 Planned End Date changed to 1 Sep 2016 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 08 Oct 2006 Status change